USPTO serial 99270216
NON-ANIMAL NAVIGATOR
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 7, 2026
- Examiner
- CHISOLM, KEVON
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with NON-ANIMAL NAVIGATOR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Carrie Webb Olson
Carrie Webb Olson Day Pitney LLPOne Federal Street - 29th FloorBoston, MA 02110United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software to assist with product development, data analysis, and management in the field of pharmaceuticals, pharmacometrics and drug research; Downloadable computer software for transmitting, analyzing and generating reports; Downloadable computer software for data processing and analysis in the fields of pharmaceuticals, pharmacometrics and drug research; Downloadable computer software for research with dashboard functionality providing grid and graphical visualizations of formatted data allowing users to analyze and visually identify relationships among histopathology, clinical chemistry, and hematology findings in the field of pharmaceutical development; Downloadable computer software in the field of pharmaceutical development facilitating simultaneous analysis of formatted data from multiple studies, data querying, mining and visualization for pharmaceutical research and development using formatted data files as data sources; Downdoadable computer software for drug development research; Downloadable software for use in modeling, simulating, and predicting pharmacokinetic and toxicological outcomes to support drug development and regulatory submissions; Downloadable computer software for use in evaluating preclinical safety using in vitro, in silico, and biosimulation methodologies. | ACTIVE | Apr 14, 2025 |
| 042 | Scientific research, namely, chemical, biochemical, and molecular analysis, research and testing services in the pharmaceutical, pharmacometrics, drug research, biotechnology and agrochemical industries, and the development and testing of new pharmaceutical products for others; Design of customized cheminformatics software for others; Consultation in the field of computer software and computer hardware design for others; Technological consultation in the field of computer networking; Software as a service (SAAS) services featuring software for data integration; Software as a service (SAAS) services featuring software for creating a network of disparate data; Software as a service (SAAS) services featuring software using artificial intelligence for data integration; Providing online non-downloadable software for data integration; Providing online non-downloadable software for creating networks of disparate data; Providing online non-downloadable software using artificial intelligence for data integration; Providing temporary use of non-downloadable computer software for integrating various databases in the fields of pharmaceuticals, pharmacometrics, drug research and logical data modeling; Providing temporary use of non-downloadable software for the collection, tracking, editing, organizing, analyzing, transmission, storage and sharing of data and information; Platform as a service (PAAS) featuring computer software platforms for predictive data analytics, data modeling and analytics; Providing online non-downloadable software for data input, integration and analytics in the fields of pharmaceuticals, pharmacometrics and drug research; Consultancy in the fields of information technology, pharmacology and software design; Software as a service (SAAS) featuring software for modeling, simulating, and analyzing biological and pharmacological data to support drug development; Providing temporary use of non-downloadable software for predicting preclinical safety outcomes using biosimulation and artificial intelligence; Consulting services in the field of scientific and technological research related to testing alternatives for pharmaceuticals; Consulting services in the field of pharmaceutical drug development, namely, advising on testing methods, toxicological data interpretation, and regulatory strategy related to preclinical safety assessment | ACTIVE | Apr 14, 2025 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Certara USA, Inc.
- Other trademarks owned by Certara USA, Inc.
- Other trademarks owned by Certara USA, Inc.
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named NON-ANIMAL NAVIGATOR
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 7, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 7, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 17, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 17, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 11, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 20, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 14, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 13, 2026 | ALIE | ASSIGNED TO LIE | — |
| Jan 13, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 13, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 13, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 9, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 9, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 9, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 25, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 25, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 25, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 24, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 16, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 7, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 7, 2025 | NWAP | NEW APPLICATION ENTERED | — |